{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:49:30Z","timestamp":1791946170868,"version":"4.3.4"},"publisher-location":"Cham","reference-count":120,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031096822","type":"print"},{"value":"9783031096839","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/7854_2021_294","type":"book-chapter","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T06:30:34Z","timestamp":1642055434000},"page":"397-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications"],"prefix":"10.1007","author":[{"given":"Mandakh","family":"Bekhbat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Treadway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Felger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"294_CR1","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","volume":"45","author":"CG Abdallah","year":"2020","unstructured":"Abdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M, Sherif M, Ahn KH, D'Souza DC, Formica R, Southwick SM, Duman RS, Sanacora G, Krystal JH (2020) Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology 45:990\u2013997","journal-title":"Neuropsychopharmacology"},{"key":"294_CR2","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.7717\/peerj.429","volume":"2","author":"R Ameli","year":"2014","unstructured":"Ameli R, Luckenbaugh DA, Gould NF, Holmes MK, Lally N, Ballard ED, Zarate CA Jr (2014) SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administration. Peer J 2:e429","journal-title":"Peer J"},{"key":"294_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fpsyt.2019.00458","volume":"10","author":"G Arteaga-Henr\u00edquez","year":"2019","unstructured":"Arteaga-Henr\u00edquez G, Simon MS, Burger B, Weidinger E, Wijkhuijs A, Arolt V, Birkenhager TK, Musil R, M\u00fcller N, Drexhage HA (2019) Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium. Front Psychiatry 10:458","journal-title":"Front Psychiatry"},{"key":"294_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/brain\/awz093","volume":"142","author":"M Avram","year":"2019","unstructured":"Avram M, Brandl F, Cabello J, Leucht C, Scherr M, Mustafa M, Leucht S, Ziegler S, Sorg C (2019) Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms. Brain 142:1813\u20131826","journal-title":"Brain"},{"key":"294_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/npp.2016.169","volume":"42","author":"J Barnes","year":"2017","unstructured":"Barnes J, Mondelli V, Pariante CM (2017) Genetic contributions of inflammation to depression. Neuropsychopharmacology 42:81\u201398","journal-title":"Neuropsychopharmacology"},{"key":"294_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbi.2020.03.015","volume":"88","author":"M Bekhbat","year":"2020","unstructured":"Bekhbat M, Treadway MT, Goldsmith DR, Woolwine BJ, Haroon E, Miller AH, Felger JC (2020) Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia. Brain Behav Immun 88:161\u2013165","journal-title":"Brain Behav Immun"},{"key":"294_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1741-7015-11-200","volume":"11","author":"M Berk","year":"2013","unstructured":"Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200","journal-title":"BMC Med"},{"key":"294_CR8","first-page":"100226","volume":"13","author":"E Bondy","year":"2021","unstructured":"Bondy E, Norton SA, Voss MD, Marks RB, Bourdreaux MJ, Treadway MT, Oltmans TF, Bogdan R (2021) Inflammation is associated with future depressive symptoms among older adults. Brain Behav Immun 13:100226","journal-title":"Brain Behav Immun"},{"key":"294_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2015.06.012","volume":"51","author":"JE Bower","year":"2016","unstructured":"Bower JE, Irwin MR (2016) Mind-body therapies and control of inflammatory biology: a descriptive review. Brain Behav Immun 51:1\u201311","journal-title":"Brain Behav Immun"},{"key":"294_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.psyneuen.2018.11.024","volume":"102","author":"CC Boyle","year":"2019","unstructured":"Boyle CC, Kuhlman KR, Dooley LN, Haydon MD, Robles TF, Ang YS, Pizzagalli DA, Bower JE (2019) Inflammation and dimensions of reward processing following exposure to the influenza vaccine. Psychoneuroendocrinology 102:16\u201323","journal-title":"Psychoneuroendocrinology"},{"key":"294_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbi.2021.01.016","volume":"93","author":"K Burrows","year":"2021","unstructured":"Burrows K, Stewart JL, Kuplicki R, Figueroa-Hall L, Spechler PA, Zheng H, Guinjoan SM, Tulsa I, Savitz JB, Kent Teague T, Paulus MP (2021) Elevated peripheral inflammation is associated with attenuated striatal reward anticipation in major depressive disorder. Brain Behav Immun 93:214\u2013225","journal-title":"Brain Behav Immun"},{"key":"294_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","volume":"26","author":"L Capuron","year":"2002","unstructured":"Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH (2002) Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26:643\u2013652","journal-title":"Neuropsychopharmacology"},{"key":"294_CR13","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/sj.npp.1301362","volume":"32","author":"L Capuron","year":"2007","unstructured":"Capuron L, Pagnoni G, Demetrashvili MF, Lawson DH, Fornwalt FB, Woolwine B, Berns GS, Nemeroff CB, Miller AH (2007) Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 32:2384\u20132392","journal-title":"Neuropsychopharmacology"},{"key":"294_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.biopsych.2010.12.006","volume":"70","author":"L Capuron","year":"2011","unstructured":"Capuron L, Schroecksnadel S, Feart C, Aubert A, Higueret D, Barberger-Gateau P, Laye S, Fuchs D (2011) Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry 70:175\u2013182","journal-title":"Biol Psychiatry"},{"key":"294_CR15","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2011.2094","volume":"69","author":"L Capuron","year":"2012","unstructured":"Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ, Votaw JR, Goodman MM, Miller AH (2012) Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry 69:1044\u20131053","journal-title":"Arch Gen Psychiatry"},{"key":"294_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/npp.2012.191","volume":"38","author":"A Cattaneo","year":"2013","unstructured":"Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM (2013) Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline \u2018predictors\u2019 and longitudinal \u2018targets\u2019. Neuropsychopharmacology 38:377\u2013385","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"294_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1192\/bjp.2018.66","volume":"214","author":"SR Chamberlain","year":"2019","unstructured":"Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, Bullmore ET (2019) Treatment-resistant depression and peripheral C-reactive protein. Br J Psychiatry 214(1):11\u201319","journal-title":"Br J Psychiatry"},{"key":"294_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1037\/abn0000443","volume":"128","author":"JA Cooper","year":"2019","unstructured":"Cooper JA, Barch DM, Reddy LF, Horan WP, Green MF, Treadway MT (2019) Effortful goal-directed behavior in schizophrenia: computational subtypes and associations with cognition. J Abnorm Psychol 128:710","journal-title":"J Abnorm Psychol"},{"key":"294_CR19","doi-asserted-by":"publisher","first-page":"e027925","DOI":"10.1136\/bmjopen-2018-027925","volume":"9","author":"H Costello","year":"2019","unstructured":"Costello H, Gould RL, Abrol E, Howard R (2019) Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open 9:e027925","journal-title":"BMJ Open"},{"issue":"8","key":"294_CR20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00702-014-1187-1","volume":"121","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Walker AK (2014) Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm 121(8):925\u2013932","journal-title":"J Neural Transm"},{"key":"294_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","volume":"169","author":"A Demjaha","year":"2012","unstructured":"Demjaha A, Murray RM, McGuire PK, Kapur S, Howes OD (2012) Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry 169:1203\u20131210","journal-title":"Am J Psychiatry"},{"key":"294_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbi.2015.12.011","volume":"58","author":"O Dipasquale","year":"2016","unstructured":"Dipasquale O, Cooper EA, Tibble J, Voon V, Baglio F, Baselli G, Cercignani M, Harrison NA (2016) Interferon-alpha acutely impairs whole-brain functional connectivity network architecture - a preliminary study. Brain Behav Immun 58:31\u201339","journal-title":"Brain Behav Immun"},{"issue":"Suppl 2","key":"294_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato DJ, Quan N, Godbout JP (2016) Neuroinflammation: the devil is in the details. J Neurochem 139(Suppl 2):136\u2013153","journal-title":"J Neurochem"},{"key":"294_CR24","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","volume":"29","author":"C D'Mello","year":"2009","unstructured":"D'Mello C, Le T, Swain MG (2009) Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci Off J Soc Neurosci 29:2089\u20132102","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"294_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.biopsych.2015.05.015","volume":"79","author":"NG Dowell","year":"2016","unstructured":"Dowell NG, Cooper EA, Tibble J, Voon V, Critchley HD, Cercignani M, Harrison NA (2016) Acute changes in striatal microstructure predict the development of interferon-alpha induced fatigue. Biol Psychiatry 79:320\u2013328","journal-title":"Biol Psychiatry"},{"key":"294_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuroscience.2017.12.040","volume":"403","author":"NG Dowell","year":"2019","unstructured":"Dowell NG, Bouyagoub S, Tibble J, Voon V, Cercignani M, Harrison NA (2019) Interferon-alpha-induced changes in NODDI predispose to the development of fatigue. Neuroscience 403:111\u2013117","journal-title":"Neuroscience"},{"key":"294_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457","journal-title":"Biol Psychiatry"},{"key":"294_CR28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/npp.2017.231","volume":"43","author":"A Draper","year":"2018","unstructured":"Draper A, Koch RM, van der Meer JW, Aj Apps M, Pickkers P, Husain M, van der Schaaf ME (2018) Effort but not reward sensitivity is altered by acute sickness induced by experimental endotoxemia in humans. Neuropsychopharmacology 43:1107\u20131118","journal-title":"Neuropsychopharmacology"},{"key":"294_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/annrheumdis-2015-208490","volume":"75","author":"L Dreyer","year":"2016","unstructured":"Dreyer L, Magyari M, Laursen B, Cordtz R, Sellebjerg F, Locht H (2016) Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry. Ann Rheum Dis 75:785\u2013786","journal-title":"Ann Rheum Dis"},{"key":"294_CR30","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1038\/npp.2017.67","volume":"42","author":"DP Eisenberg","year":"2017","unstructured":"Eisenberg DP, Yankowitz L, Ianni AM, Rubinstein DY, Kohn PD, Hegarty CE, Gregory MD, Apud JA, Berman KF (2017) Presynaptic dopamine synthesis capacity in schizophrenia and striatal blood flow change during antipsychotic treatment and medication-free conditions. Neuropsychopharmacology 42:2232\u20132241","journal-title":"Neuropsychopharmacology"},{"key":"294_CR31","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","volume":"68","author":"NI Eisenberger","year":"2010","unstructured":"Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR (2010) Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 68:748\u2013754","journal-title":"Biol Psychiatry"},{"key":"294_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/npp.2016.217","volume":"42","author":"R Escalona","year":"2017","unstructured":"Escalona R, Fawcett J (2017) Pramipexole in treatment resistant-depression, possible role of inflammatory cytokines. Neuropsychopharmacology 42:363","journal-title":"Neuropsychopharmacology"},{"key":"294_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pnpbp.2014.10.003","volume":"57","author":"HA Eyre","year":"2015","unstructured":"Eyre HA, Air T, Proctor S, Rositano S, Baune BT (2015) A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog Neuro-Psychopharmacol Biol Psychiatry 57:11\u201316","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"294_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","volume":"246","author":"JC Felger","year":"2013","unstructured":"Felger JC, Lotrich FE (2013) Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246:199\u2013229","journal-title":"Neuroscience"},{"key":"294_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","volume":"33","author":"JC Felger","year":"2012","unstructured":"Felger JC, Miller AH (2012) Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol 33:315\u2013327","journal-title":"Front Neuroendocrinol"},{"key":"294_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/npp.2016.143","volume":"42","author":"JC Felger","year":"2017","unstructured":"Felger JC, Treadway MT (2017) Inflammation effects on motivation and motor activity: role of dopamine. Neuropsychopharmacology 42:216\u2013241","journal-title":"Neuropsychopharmacology"},{"key":"294_CR37","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.biopsych.2007.05.026","volume":"62","author":"JC Felger","year":"2007","unstructured":"Felger JC, Alagbe O, Hu F, Mook D, Freeman AA, Sanchez MM, Kalin NH, Ratti E, Nemeroff CB, Miller AH (2007) Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry 62:1324\u20131333","journal-title":"Biol Psychiatry"},{"key":"294_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbi.2012.10.010","volume":"31","author":"JC Felger","year":"2013","unstructured":"Felger JC, Li L, Marvar PJ, Woolwine BJ, Harrison DG, Raison CL, Miller AH (2013a) Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations. Brain Behav Immun 31:153\u2013160","journal-title":"Brain Behav Immun"},{"key":"294_CR39","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/npp.2013.115","volume":"38","author":"JC Felger","year":"2013","unstructured":"Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR, Freeman AA, Rye DB, Goodman MM, Howell LL, Miller AH (2013b) Chronic interferon-alpha decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology 38:2179\u20132187","journal-title":"Neuropsychopharmacology"},{"key":"294_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu084","volume":"18","author":"JC Felger","year":"2015","unstructured":"Felger JC, Hernandez CR, Miller AH (2015) Levodopa reverses cytokine-induced reductions in striatal dopamine release. Int J Neuropsychopharmacol 18:1\u20135","journal-title":"Int J Neuropsychopharmacol"},{"key":"294_CR41","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/mp.2015.168","volume":"21","author":"JC Felger","year":"2016","unstructured":"Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, Miller AH (2016) Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry 21:1358\u20131365","journal-title":"Mol Psychiatry"},{"key":"294_CR42","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41380-018-0096-3","volume":"25","author":"JC Felger","year":"2020","unstructured":"Felger JC, Haroon E, Patel TA, Goldsmith DR, Wommack EC, Woolwine BJ, Le NA, Feinberg R, Tansey MG, Miller AH (2020) What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry 25:1301\u20131311","journal-title":"Mol Psychiatry"},{"key":"294_CR43","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, Miller AH, Mantovani A, Weyand CM, Barzilai N, Goronzy JJ, Rando TA, Effros RB, Lucia A, Kleinstreuer N, Slavich GM (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25:1822\u20131832","journal-title":"Nat Med"},{"key":"294_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fpsyt.2020.00046","volume":"11","author":"DR Goldsmith","year":"2020","unstructured":"Goldsmith DR, Rapaport MH (2020) Inflammation and negative symptoms of schizophrenia: implications for reward processing and motivational deficits. Front Psychiatry 11:46","journal-title":"Front Psychiatry"},{"key":"294_CR45","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21:1696\u20131709","journal-title":"Mol Psychiatry"},{"key":"294_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.schres.2018.02.048","volume":"199","author":"DR Goldsmith","year":"2018","unstructured":"Goldsmith DR, Haroon E, Miller AH, Strauss GP, Buckley PF, Miller BJ (2018) TNF-alpha and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia. Schizophr Res 199:281\u2013284","journal-title":"Schizophr Res"},{"key":"294_CR47","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/npp.2014.25","volume":"39","author":"E Haroon","year":"2014","unstructured":"Haroon E, Woolwine BJ, Chen X, Pace TW, Parekh S, Spivey JR, Hu XP, Miller AH (2014) IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy. Neuropsychopharmacology 39:1777\u20131785","journal-title":"Neuropsychopharmacology"},{"key":"294_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbi.2014.12.004","volume":"46","author":"E Haroon","year":"2015","unstructured":"Haroon E, Felger JC, Woolwine BJ, Chen X, Parekh S, Spivey JR, Hu XP, Miller AH (2015) Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: preliminary findings. Brain Behav Immun 46:17\u201322","journal-title":"Brain Behav Immun"},{"key":"294_CR49","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/mp.2015.206","volume":"21","author":"E Haroon","year":"2016","unstructured":"Haroon E, Fleischer CC, Felger JC, Chen X, Woolwine BJ, Patel T, Hu XP, Miller AH (2016) Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Mol Psychiatry 21:1351\u20131357","journal-title":"Mol Psychiatry"},{"key":"294_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/npp.2016.199","volume":"42","author":"E Haroon","year":"2017","unstructured":"Haroon E, Miller AH, Sanacora G (2017) Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacology 42:193\u2013215","journal-title":"Neuropsychopharmacology"},{"key":"294_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41398-018-0241-4","volume":"8","author":"E Haroon","year":"2018","unstructured":"Haroon E, Chen X, Li Z, Patel T, Woolwine BJ, Hu XP, Felger JC, Miller AH (2018a) Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia. Transl Psychiatry 8:189","journal-title":"Transl Psychiatry"},{"key":"294_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","volume":"95","author":"E Haroon","year":"2018","unstructured":"Haroon E, Daguanno AW, Woolwine BJ, Goldsmith DR, Baer WM, Wommack EC, Felger JC, Miller AH (2018b) Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology 95:43\u201349","journal-title":"Psychoneuroendocrinology"},{"key":"294_CR53","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41386-020-0607-1","volume":"45","author":"E Haroon","year":"2020","unstructured":"Haroon E, Welle JR, Woolwine BJ, Goldsmith DR, Baer W, Patel T, Felger JC, Miller AH (2020) Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression. Neuropsychopharmacology 45:998\u20131007","journal-title":"Neuropsychopharmacology"},{"key":"294_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","volume":"66","author":"NA Harrison","year":"2009","unstructured":"Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD (2009) Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66:407\u2013414","journal-title":"Biol Psychiatry"},{"key":"294_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.biopsych.2015.07.018","volume":"80","author":"NA Harrison","year":"2016","unstructured":"Harrison NA, Voon V, Cercignani M, Cooper EA, Pessiglione M, Critchley HD (2016) A neurocomputational account of how inflammation enhances sensitivity to punishments versus rewards. Biol Psychiatry 80:73\u201381","journal-title":"Biol Psychiatry"},{"key":"294_CR56","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1152\/physrev.00049.2005","volume":"86","author":"PG Haydon","year":"2006","unstructured":"Haydon PG, Carmignoto G (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86:1009\u20131031","journal-title":"Physiol Rev"},{"key":"294_CR57","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","volume":"150","author":"CH Hennekens","year":"2005","unstructured":"Hennekens CH, Hennekens AR, Hollar D, Casey DE (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J 150:1115\u20131121","journal-title":"Am Heart J"},{"key":"294_CR58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171\u2013186","journal-title":"Psychosom Med"},{"key":"294_CR59","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S2215-0366(20)30138-3","volume":"7","author":"MI Husain","year":"2020","unstructured":"Husain MI, Chaudhry IB, Khoso AB, Husain MO, Hodsoll J, Ansari MA, Naqvi HA, Minhas FA, Carvalho AF, Meyer JH, Deakin B, Mulsant BH, Husain N, Young AH (2020) Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial. Lancet Psychiatry 7:515\u2013527","journal-title":"Lancet Psychiatry"},{"key":"294_CR60","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1172\/JCI28508","volume":"116","author":"Y Iwakura","year":"2006","unstructured":"Iwakura Y, Ishigame H (2006) The IL-23\/IL-17 axis in inflammation. J Clin Invest 116:1218\u20131222","journal-title":"J Clin Invest"},{"key":"294_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbi.2012.12.008","volume":"31","author":"M Iwata","year":"2013","unstructured":"Iwata M, Ota KT, Duman RS (2013) The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun 31:105\u2013114","journal-title":"Brain Behav Immun"},{"key":"294_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.01.023","volume":"78","author":"MK Jha","year":"2017","unstructured":"Jha MK, Minhajuddin A, Gadad BS, Greer T, Grannemann B, Soyombo A, Mayes TL, Rush AJ, Trivedi MH (2017) Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial. Psychoneuroendocrinology 78:105\u2013113","journal-title":"Psychoneuroendocrinology"},{"key":"294_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.05.017","volume":"95","author":"MK Jha","year":"2018","unstructured":"Jha MK, Miller AH, Minhajuddin A, Trivedi MH (2018) Association of T and non-T cell cytokines with anhedonia: role of gender differences. Psychoneuroendocrinology 95:1\u20137","journal-title":"Psychoneuroendocrinology"},{"key":"294_CR64","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s002130000549","volume":"152","author":"FD Juengling","year":"2000","unstructured":"Juengling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU, Bauer J, Lieb K (2000) Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology 152:383\u2013389","journal-title":"Psychopharmacology"},{"key":"294_CR65","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","volume":"72","author":"RH Kaiser","year":"2015","unstructured":"Kaiser RH, Andrews-Hanna JR, Wager TD, Pizzagalli DA (2015) Large-scale network dysfunction in major depressive disorder: a meta-analysis of resting-state functional connectivity. JAMA Psychiatry 72:603\u2013611","journal-title":"JAMA Psychiatry"},{"key":"294_CR66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","volume":"23","author":"N Kappelmann","year":"2018","unstructured":"Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM (2018) Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry 23:335\u2013343","journal-title":"Mol Psychiatry"},{"issue":"3","key":"294_CR120","doi-asserted-by":"publisher","first-page":"G508","DOI":"10.1152\/ajpgi.00269.2003","volume":"286","author":"H Kazumori","year":"2004","unstructured":"Kazumori H, Ishihara S, Rumi MA, Ortega-Cava CF, Kadowaki Y, Kinoshita Y (2004) Transforming growth factor-alpha directly augments histidine decarboxylase and vesicular monoamine transporter 2 production in rat enterochromaffin-like cells. Am J Physiol Gastrointest Liver Physiol 286(3):G508\u2013G514","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"294_CR67","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/npp.2016.258","volume":"42","author":"E Kim","year":"2017","unstructured":"Kim E, Howes OD, Veronese M, Beck K, Seo S, Park JW, Lee JS, Lee YS, Kwon JS (2017) Presynaptic dopamine capacity in patients with treatment-resistant schizophrenia taking clozapine: an [(18)F]DOPA PET study. Neuropsychopharmacology 42:941\u2013950","journal-title":"Neuropsychopharmacology"},{"key":"294_CR68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2020.12.016","volume":"54","author":"AM Klawonn","year":"2021","unstructured":"Klawonn AM, Fritz M, Castany S, Pignatelli M, Canal C, Simila F, Tejeda HA, Levinsson J, Jaarola M, Jakobsson J, Hidalgo J, Heilig M, Bonci A, Engblom D (2021) Microglial activation elicits a negative affective state through prostaglandin-mediated modulation of striatal neurons. Immunity 54:225\u2013234.e6","journal-title":"Immunity"},{"key":"294_CR69","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370\u2013379","journal-title":"Neuropsychopharmacology"},{"key":"294_CR70","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1038\/s41380-020-00869-2","volume":"26","author":"J Lasselin","year":"2021","unstructured":"Lasselin J, Lekander M, Benson S, Schedlowski M, Engler H (2021) Sick for science: experimental endotoxemia as a translational tool to develop and test new therapies for inflammation-associated depression. Mol Psychiatry 26:3672\u20133683","journal-title":"Mol Psychiatry"},{"key":"294_CR71","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbi.2020.04.063","volume":"88","author":"Y Lee","year":"2020","unstructured":"Lee Y, Mansur RB, Brietzke E, Carmona NE, Subramaniapillai M, Pan Z, Shekotikhina M, Rosenblat JD, Suppes T, Cosgrove VE, Kramer NE, McIntyre RS (2020) Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I\/II depression. Brain Behav Immun 88:631\u2013639","journal-title":"Brain Behav Immun"},{"key":"294_CR72","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biopsych.2019.11.017","volume":"88","author":"ME Lynall","year":"2020","unstructured":"Lynall ME, Turner L, Bhatti J, Cavanagh J, de Boer P, Mondelli V, Jones D, Drevets WC, Cowen P, Harrison NA, Pariante CM, Pointon L, Clatworthy MR, Bullmore E, Neuroimmunology of Mood Disorders and Alzheimer\u2019s Disease (NIMA) Consortium (2020) Peripheral blood cell-stratified subgroups of inflamed depression. Biol Psychiatry 88:185\u2013196","journal-title":"Biol Psychiatry"},{"key":"294_CR73","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jaac.2012.01.011","volume":"51","author":"DL McMakin","year":"2012","unstructured":"McMakin DL, Olino TM, Porta G, Dietz LJ, Emslie G, Clarke G, Wagner KD, Asarnow JR, Ryan ND, Birmaher B, Shamseddeen W, Mayes T, Kennard B, Spirito A, Keller M, Lynch FL, Dickerson JF, Brent DA (2012) Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. J Am Acad Child Adolesc Psychiatry 51:404\u2013411","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"294_CR74","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/scan\/nsz100","volume":"15","author":"ND Mehta","year":"2020","unstructured":"Mehta ND, Stevens JS, Li Z, Gillespie CF, Fani N, Michopoulos V, Felger JC (2020) Inflammation, reward circuitry and symptoms of anhedonia and PTSD in trauma-exposed women. Soc Cogn Affect Neurosci 15(10):1046\u20131055","journal-title":"Soc Cogn Affect Neurosci"},{"key":"294_CR75","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","volume":"20","author":"C Menard","year":"2017","unstructured":"Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, Janssen WG, Labonte B, Parise EM, Lorsch ZS, Golden SA, Heshmati M, Tamminga C, Turecki G, Campbell M, Fayad ZA, Tang CY, Merad M, Russo SJ (2017) Social stress induces neurovascular pathology promoting depression. Nat Neurosci 20:1752\u20131760","journal-title":"Nat Neurosci"},{"key":"294_CR76","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1176\/appi.ajp.159.5.746","volume":"159","author":"MJ Mentis","year":"2002","unstructured":"Mentis MJ, McIntosh AR, Perrine K, Dhawan V, Berlin B, Feigin A, Edwards C, Mattis P, Eidelberg D (2002) Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson\u2019s disease. Am J Psychiatry 159:746\u2013754","journal-title":"Am J Psychiatry"},{"key":"294_CR77","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1176\/appi.ajp.2014.14020263","volume":"172","author":"V Michopoulos","year":"2015","unstructured":"Michopoulos V, Rothbaum AO, Jovanovic T, Almli LM, Bradley B, Rothbaum BO, Gillespie CF, Ressler KJ (2015) Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry 172:353\u2013362","journal-title":"Am J Psychiatry"},{"key":"294_CR78","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/npp.2016.167","volume":"42","author":"AH Miller","year":"2017","unstructured":"Miller AH, Haroon E, Felger JC (2017) Therapeutic implications of brain-immune interactions: treatment in translation. Neuropsychopharmacology 42:334\u2013359","journal-title":"Neuropsychopharmacology"},{"key":"294_CR79","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2017.08.022","volume":"67","author":"MW Miller","year":"2018","unstructured":"Miller MW, Maniates H, Wolf EJ, Logue MW, Schichman SA, Stone A, Milberg W, McGlinchey R (2018) CRP polymorphisms and DNA methylation of the AIM2 gene influence associations between trauma exposure, PTSD, and C-reactive protein. Brain Behav Immun 67:194\u2013202","journal-title":"Brain Behav Immun"},{"key":"294_CR80","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/npp.2015.17","volume":"40","author":"M Moieni","year":"2015","unstructured":"Moieni M, Irwin MR, Jevtic I, Olmstead R, Breen EC, Eisenberger NI (2015) Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology 40:1709\u20131716","journal-title":"Neuropsychopharmacology"},{"key":"294_CR81","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","volume":"41","author":"V Mondelli","year":"2015","unstructured":"Mondelli V, Ciufolini S, Belvederi Murri M, Bonaccorso S, Di Forti M, Giordano A, Marques TR, Zunszain PA, Morgan C, Murray RM, Pariante CM, Dazzan P (2015) Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis. Schizophr Bull 41:1162\u20131170","journal-title":"Schizophr Bull"},{"key":"294_CR82","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.1523\/JNEUROSCI.23-24-08480.2003","volume":"23","author":"JA Moron","year":"2003","unstructured":"Moron JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM, Lin ZC, Wang JB, Javitch JA, Galli A, Shippenberg TS (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23:8480\u20138488","journal-title":"J Neurosci"},{"key":"294_CR83","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/schbul\/sbv151","volume":"42","author":"E Mouchlianitis","year":"2016","unstructured":"Mouchlianitis E, Bloomfield MA, Law V, Beck K, Selvaraj S, Rasquinha N, Waldman A, Turkheimer FE, Egerton A, Stone J, Howes OD (2016) Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive. Schizophr Bull 42:744\u2013752","journal-title":"Schizophr Bull"},{"key":"294_CR84","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","volume":"47","author":"K Munkholm","year":"2013","unstructured":"Munkholm K, Brauner JV, Kessing LV, Vinberg M (2013) Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res 47:1119\u20131133","journal-title":"J Psychiatr Res"},{"key":"294_CR85","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/15622975.2015.1062552","volume":"16","author":"C Noto","year":"2015","unstructured":"Noto C, Maes M, Ota VK, Teixeira AL, Bressan RA, Gadelha A, Brietzke E (2015) High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance. World J Biol Psychiatry 16:422\u2013429","journal-title":"World J Biol Psychiatry"},{"key":"294_CR86","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00213-013-3285-4","volume":"231","author":"EJ Nunes","year":"2014","unstructured":"Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA, Baqi Y, Muller CE, Correa M, Salamone JD (2014) Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5\/chow feeding choice task. Psychopharmacology 231:727\u2013736","journal-title":"Psychopharmacology"},{"key":"294_CR87","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O'Neill","year":"2016","unstructured":"O'Neill LA, Kishton RJ, Rathmell J (2016) A guide to immunometabolism for immunologists. Nat Rev Immunol 16:553\u2013565","journal-title":"Nat Rev Immunol"},{"key":"294_CR88","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","volume":"2","author":"IC Passos","year":"2015","unstructured":"Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J, Salum G, Magalh\u00e3es PV, Kapczinski F, Kauer-Sant'Anna M (2015) Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2:1002\u20131012","journal-title":"Lancet Psychiatry"},{"key":"294_CR89","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/schbul\/sby038","volume":"44","author":"JG Pouget","year":"2018","unstructured":"Pouget JG (2018) The emerging immunogenetic architecture of schizophrenia. Schizophr Bull 44:993\u20131004","journal-title":"Schizophr Bull"},{"key":"294_CR90","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15:393\u2013403","journal-title":"Mol Psychiatry"},{"key":"294_CR91","unstructured":"Raison CL, Felger JC, Miller AH (2013a) Inflammation and treatment resistance in major depression: a perfect storm. Psychiatric Times"},{"key":"294_CR92","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013b) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70:31\u201341","journal-title":"JAMA Psychiatry"},{"key":"294_CR93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/mp.2015.22","volume":"21","author":"MH Rapaport","year":"2016","unstructured":"Rapaport MH, Nierenberg AA, Schettler PJ, Kinkead B, Cardoos A, Walker R, Mischoulon D (2016) Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Mol Psychiatry 21:71\u201379","journal-title":"Mol Psychiatry"},{"key":"294_CR94","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbi.2020.09.004","volume":"91","author":"M Rengasamy","year":"2021","unstructured":"Rengasamy M, Marsland A, McClain L, Kovats T, Walko T, Pan L, Price RB (2021) Longitudinal relationships of cytokines, depression and anhedonia in depressed adolescents. Brain Behav Immun 91:74\u201380","journal-title":"Brain Behav Immun"},{"key":"294_CR95","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jad.2017.10.042","volume":"227","author":"JD Rosenblat","year":"2018","unstructured":"Rosenblat JD, McIntyre RS (2018) Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials. J Affect Disord 227:219\u2013225","journal-title":"J Affect Disord"},{"key":"294_CR96","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.biopsych.2019.04.007","volume":"86","author":"BR Rutherford","year":"2019","unstructured":"Rutherford BR, Slifstein M, Chen C, Abi-Dargham A, Brown PJ, Wall MW, Vanegas-Arroyave N, Stern Y, Bailey V, Valente E, Roose SP (2019) Effects of L-DOPA monotherapy on psychomotor speed and [(11)C]Raclopride binding in high-risk older adults with depression. Biol Psychiatry 86:221\u2013229","journal-title":"Biol Psychiatry"},{"key":"294_CR97","first-page":"228","volume":"43","author":"G Salvadore","year":"2018","unstructured":"Salvadore G, Nash A, Bleys C, Hsu B, Saad Z, Gause A, Moyer J, Xi L, Manji H, Van Nueten L, Drevets W (2018) A double-blind, placebo-controlled, multicenter study of Sirukumab as adjunctive treatment to a monoaminergic antidepressant in adults with major depressive disorder, in ACNP 57th annual meeting: poster session II, Hollywood, FL. Neuropsychopharmacology 43:228\u2013382","journal-title":"Neuropsychopharmacology"},{"key":"294_CR98","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0891-5849(03)00317-4","volume":"35","author":"A Santamaria","year":"2003","unstructured":"Santamaria A, Flores-Escartin A, Martinez JC, Osorio L, Galvan-Arzate S, Pedraza-Chaverri J, Maldonado PD, Medina-Campos ON, Jimenez-Capdeville ME, Manjarrez J, Rios C (2003) Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems. Free Radic Biol Med 35:418\u2013427","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"294_CR99","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25(1):131\u2013147","journal-title":"Mol Psychiatry"},{"key":"294_CR100","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.07.609","volume":"62","author":"J Savitz","year":"2015","unstructured":"Savitz J, Dantzer R, Meier TB, Wurfel BE, Victor TA, McIntosh SA, Ford BN, Morris HM, Bodurka J, Teague TK, Drevets WC (2015) Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder. Psychoneuroendocrinology 62:54\u201358","journal-title":"Psychoneuroendocrinology"},{"key":"294_CR101","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.4088\/JCP.14m09587","volume":"76","author":"RC Shelton","year":"2015","unstructured":"Shelton RC, Pencina MJ, Barrentine LW, Ruiz JA, Fava M, Zajecka JM, Papakostas GI (2015) Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs. J Clin Psychiatry 76:1635\u20131641","journal-title":"J Clin Psychiatry"},{"key":"294_CR102","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41386-020-0779-8","volume":"46","author":"HE Soder","year":"2021","unstructured":"Soder HE, Cooper JA, Lopez-Gamundi P, Hoots JK, Nunez C, Lawlor VM, Lane SD, Treadway MT, Wardle MC (2021) Dose-response effects of d-amphetamine on effort-based decision-making and reinforcement learning. Neuropsychopharmacology 46:1078\u20131085","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"294_CR103","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1176\/appi.ajp.2011.11030447","volume":"169","author":"GP Strauss","year":"2012","unstructured":"Strauss GP, Gold JM (2012) A new perspective on anhedonia in schizophrenia. Am J Psychiatr 169(4):364\u2013373","journal-title":"Am J Psychiatr"},{"key":"294_CR104","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neubiorev.2016.02.017","volume":"64","author":"W Swardfager","year":"2016","unstructured":"Swardfager W, Rosenblat JD, Benlamri M, McIntyre RS (2016) Mapping inflammation onto mood: inflammatory mediators of anhedonia. Neurosci Biobehav Rev 64:148\u2013166","journal-title":"Neurosci Biobehav Rev"},{"key":"294_CR105","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","volume":"40","author":"RG Tavares","year":"2002","unstructured":"Tavares RG, Tasca CI, Santos CES, Alves LB, Porciuncula LO, Emanuelli T, Souza DO (2002) Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 40:621\u2013627","journal-title":"Neurochem Int"},{"key":"294_CR106","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.biopsych.2017.02.1183","volume":"82","author":"MT Treadway","year":"2017","unstructured":"Treadway MT, Admon R, Arulpragasam AR, Mehta M, Douglas S, Vitaliano G, Olson DP, Cooper JA, Pizzagalli DA (2017) Association between interleukin-6 and striatal prediction-error signals following acute stress in healthy female participants. Biol Psychiatry 82:570\u2013577","journal-title":"Biol Psychiatry"},{"key":"294_CR107","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1017\/S0033291711001905","volume":"42","author":"R Uher","year":"2012","unstructured":"Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, Hauser J, Dernovsek MZ, Souery D, Bajs M, Maier W, Aitchison KJ, Farmer A, McGuffin P (2012) Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med 42:967\u2013980","journal-title":"Psychol Med"},{"key":"294_CR108","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","volume":"171","author":"R Uher","year":"2014","unstructured":"Uher R, Tansey KE, Dew T, Maier W, Mors O, Hauser J, Dernovsek MZ, Henigsberg N, Souery D, Farmer A, McGuffin P (2014) An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry 171:1278\u20131286","journal-title":"Am J Psychiatry"},{"key":"294_CR109","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1038\/npp.2014.141","volume":"39","author":"EG Vichaya","year":"2014","unstructured":"Vichaya EG, Hunt SC, Dantzer R (2014) Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in mice. Neuropsychopharmacology 39:2884\u20132890","journal-title":"Neuropsychopharmacology"},{"key":"294_CR110","first-page":"12","volume":"2","author":"X Wang","year":"2010","unstructured":"Wang X, Michaelis EK (2010) Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci 2:12","journal-title":"Front Aging Neurosci"},{"key":"294_CR111","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/npp.2016.102","volume":"42","author":"MD Weber","year":"2017","unstructured":"Weber MD, Godbout JP, Sheridan JF (2017) Repeated social defeat, Neuroinflammation, and behavior: monocytes carry the signal. Neuropsychopharmacology 42:46\u201361","journal-title":"Neuropsychopharmacology"},{"key":"294_CR112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/YCO.0000000000000122","volume":"28","author":"AE Whitton","year":"2015","unstructured":"Whitton AE, Treadway MT, Pizzagalli DA (2015) Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry 28:7\u201312","journal-title":"Curr Opin Psychiatry"},{"key":"294_CR113","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.schres.2020.09.014","volume":"224","author":"AE Whitton","year":"2020","unstructured":"Whitton AE, Merchant JT, Lewandowski KE (2020) Dissociable mechanisms underpinning effort-cost decision-making across the psychosis spectrum. Schizophr Res 224:133\u2013140","journal-title":"Schizophr Res"},{"key":"294_CR114","first-page":"9","volume":"91","author":"T Wichmann","year":"2003","unstructured":"Wichmann T, DeLong MR (2003) Functional neuroanatomy of the basal ganglia in Parkinson\u2019s disease. Adv Neurol 91:9\u201318","journal-title":"Adv Neurol"},{"key":"294_CR115","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","volume":"77","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, Wang N, Yang C, Shi JY, Yu HY, Hashimoto K (2015) Serum interleukin-6 is a predictive biomarker for ketamine\u2019s antidepressant effect in treatment-resistant patients with major depression. Biol Psychiatry 77:e19\u2013e20","journal-title":"Biol Psychiatry"},{"key":"294_CR116","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.bbi.2019.05.011","volume":"80","author":"L Yin","year":"2019","unstructured":"Yin L, Xu X, Chen G, Mehta ND, Haroon E, Miller AH, Luo Y, Li Z, Felger JC (2019) Inflammation and decreased functional connectivity in a widely-distributed network in depression: centralized effects in the ventral medial prefrontal cortex. Brain Behav Immun 80:657\u2013666","journal-title":"Brain Behav Immun"},{"key":"294_CR117","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1007\/s00213-016-4392-9","volume":"233","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Arif Y, Haley A, Tripodi G, Baqi Y, Muller CE, Miguel NS, Correa M, Salamone JD (2016a) Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization. Psychopharmacology 233:3575\u20133586","journal-title":"Psychopharmacology"},{"key":"294_CR118","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00213-015-4176-7","volume":"233","author":"SE Yohn","year":"2016","unstructured":"Yohn SE, Lopez-Cruz L, Hutson PH, Correa M, Salamone JD (2016b) Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat. Psychopharmacology 233:949\u2013960","journal-title":"Psychopharmacology"},{"key":"294_CR119","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/jir.2011.0093","volume":"32","author":"H Zoller","year":"2012","unstructured":"Zoller H, Schloegl A, Schroecksnadel S, Vogel W, Fuchs D (2012) Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio. J Interferon Cytokine Res 32:216\u2013220","journal-title":"J Interferon Cytokine Res"}],"container-title":["Current Topics in Behavioral Neurosciences","Anhedonia: Preclinical, Translational, and Clinical Integration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2021_294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T16:04:19Z","timestamp":1659974659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2021_294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031096822","9783031096839"],"references-count":120,"URL":"https:\/\/doi.org\/10.1007\/7854_2021_294","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"1 January 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}